Newsletter

Nick Sundich

1,283 articles published

Mining Stocks Palladium Stocks

Zimplats (ASX:ZIM): If you thought there were no platinum miners on the ASX, you were wrong!

Anyone suggesting the only way to gain exposure to platinum on the ASX was through explorers and developers clearly haven't heard of Zimplats (ASX:ZIM). It is a company that has slipped under the radar of many Australian investors, but for how much longer? What are the Best ASX stocks to invest in right now? Check our buy/sell…

ByNick SundichFebruary 19, 20260Comments

Education Mid Cap Stocks Penny Stocks Small Caps Stocks Undervalued Stocks

ASX Company Spin: Here are 7 occasions when management tries to sell bad news as good news

In all our years, we have seen our fair share of ASX Company Spin. It is repeated because often investors fall for it. Even if not all do, it is sufficient that some investors fall for it to achieve what has to be achieved. For instance, that enough believe a capital raising at a >25% discount…

ByNick SundichFebruary 19, 20260Comments

International Stocks Tech Stocks Technology

Cisco Systems (NDQ:CSCO): Will this US$300bn company really be a winner from the AI boom? Investors aren’t so sure

As a big company in the networking equipment space, Cisco Systems (NDQ:CSCO) is a company you could be forgiven for thinking will be a winner from AI just by being there. But investor reaction to its latest results suggest investors are currently skeptical. What are the Best ASX stocks to invest in right now? Check our buy/sell…

ByNick SundichFebruary 18, 20260Comments

Biotech Stocks Healthcare Stocks Life Sciences

If you wondered why share prices fall after a capital raising, Botanix is the ‘perfect’ poster child

We thought this was a perfect time to ponder the question,' Why share prices fall after a capital raising', in light of what happened with Botanix Pharmaceuticals (ASX:BOT). Its shares fell 33% in less than an hour of trading. Now, shouldn't investors be happy that the company has $45m more cash? Let's just say that…

ByNick SundichFebruary 18, 20260Comments

Biotech Stocks Healthcare Stocks Life Sciences Small Caps Stocks Undervalued Stocks

Rhythm Biosciences (ASX:RHY): Since picking up Genetype, it has never looked back and is more than a one-trick pony!

Investors may remember Rhythm Biosciences (ASX:RHY) for its ColoSTAT test, but it is Genetype that is arguably more exciting. The company now has a substantially larger market awaiting us, and while its commercialisation strategy for ColoSTAT has changed, this strategy has been successful. Wait, has Rhythm received TGA approval? Yes and no - it's a long…

ByNick SundichFebruary 17, 20260Comments

Blue Chip Stocks Property Real Estate

GPT Group (ASX:GPT): Still hasn’t surpassed pre-COVID levels, but is it finally out of the doldrums now?

GPT Group (ASX:GPT) released its annual results (for CY25) yesterday, but the market reaction was nuanced and it remains below pre-COVID levels. Is this company just an undeserved victim of the levels of investor appetite for REITs, or is there something at the fundamental level warranting it to have not reached levels last reached 6…

ByNick SundichFebruary 17, 20260Comments

Education International Stocks

6 times Takeover Deal regulators hindered a deal involving an ASX Company!

Any M&A deal announced where both companies' boards unanimously back the deal may seem a fait accompli, but takeover deal regulators may have a thing or two to say about the deals. That is why companies say the deals are subject to scruitany, and increasing scruitany under the latest M&A regime. Regulators can block deals if…

ByNick SundichFebruary 17, 20260Comments

Gold Stocks Mining Stocks

Magnetic Resources (ASX:MAU) is being acquired by Genesis (ASX:GMD) for $639m! Which ASX gold stocks could be next?

Magnetic Resources (ASX:MAU) investors will receive a sweet return on their investment, with ASX 100 miner Genesis (ASX:GMD) buying it out for $639m, 70% of which will be in cash and 30% of it will be in Genesis scrip. It hasn't been the first gold M&A deal amidst the current bull market and probably won't be…

ByNick SundichFebruary 16, 20260Comments

Biotech Stocks Blue Chip Stocks Consumer

Here are some ASX stocks that will benefit from a higher AUD, and stocks that will lose

The Aussie dollar has been surging in recent weeks and there are ASX stocks that will benefit from a higher AUD - as well as some that will lose. We cannot be certain how much longer this run will go on for, but we do know it is on a run right now. After several quarters…

ByNick SundichFebruary 16, 20260Comments

Index Funds Industrials International Stocks

Infratil (ASX:IFT): One of the ASX’s largest infrastructure investors

Visit the website of Infratil (ASX:IFT), and the first thing you see is 'We invest in ideas that matter'. This company is an investor in infrastructure and is one of the largest on the ASX - over 30 years old and headquartered in New Zealand, listed on both exchanges. It has a diverse portfolio, but it…

ByNick SundichFebruary 16, 20260Comments

the Kick-ass Multipurpose WordPress Theme

Nick Sundich

Zimplats (ASX:ZIM): If you thought there were no platinum miners on the ASX, you were wrong!

ASX Company Spin: Here are 7 occasions when management tries to sell bad news as good news

Cisco Systems (NDQ:CSCO): Will this US$300bn company really be a winner from the AI boom? Investors aren’t so sure

If you wondered why share prices fall after a capital raising, Botanix is the ‘perfect’ poster child

Rhythm Biosciences (ASX:RHY): Since picking up Genetype, it has never looked back and is more than a one-trick pony!

GPT Group (ASX:GPT): Still hasn’t surpassed pre-COVID levels, but is it finally out of the doldrums now?

6 times Takeover Deal regulators hindered a deal involving an ASX Company!

Magnetic Resources (ASX:MAU) is being acquired by Genesis (ASX:GMD) for $639m! Which ASX gold stocks could be next?

Here are some ASX stocks that will benefit from a higher AUD, and stocks that will lose

Infratil (ASX:IFT): One of the ASX’s largest infrastructure investors

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Nick Sundich

Stocks in Spotlight

Add Your Heading Text Here